ERBB2 and extrahepatic bile duct neoplasm: Nakasawa et al. [18] studied tyrosine kinase receptor proteins expression by in 221 biliary tract carcinomas and found that overexpression of ErbB-2 was found in 16% of carcinomas of the gallbladder and a slightly lower percentage of extrahepatic bile duct tumors.